FDA Orders New Label For Biogen Idec's MS Drug By: Benzinga via Benzinga November 25, 2014 at 14:05 PM EST Biogen Idec Inc (NASDAQ: BIIB) was little changed Tuesday when regulators ordered new labeling information for its blockbuster ... Read More >> Related Stocks: Biogen Idec